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Oi3' . s . This study was undertaken to examine the effects of
coronary flow dynamics after thromboty -.k : xn infarct size limits-
60.
It
	
commonly accepted that early
its d not necessarily salvage inf myocardium. u-
sIble causes for my include such feelers as
elapsed time to re , residual collateral vessels,
ymunk loads, p red injury
. Re-
cently, no phenomenon has been elucidated to be
associated with h9mvi extension in clinical studies employing
con by or thallium scin phy .
Me". N
patients with early re in acute
an my i f comparable clinical back-
ground studied . The patients were clasified into two groups
on the basis of pattern iutlon measurements of great
cwdw vein low after reps group A, 9 patients with a
progressive decrease in great cardiac vein flow during the Ist 24 It
of the easel of inf. ; and group fl, 10 patients without this
obwvadw. Left ventricular ejection fraction and thallium, per .
fusion defect were compared between the two groups at follow-up.
Res were no t d in s
Although reperfusion therapy for acute myocardial infarc-
tion is reported to ameliorate ischemic damage, several
investigators (1-3) have suggested that coronary reperfusion
in the clinical setting does not necessarily lead to improved
left ventricular function . Factors that might limit the benefits
of early reperfusion include severe residual coronary steno-
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hemodyna is variables between groups A,- -id B, and neither
group had recurrent ischemic events supp- Ing reocclusion or
resten during the study . In group A, € great cardiac vein
How ( t SD 44 t 17% reduction) s_ l] oxygen extraction
(38 :t 15% reduction) were progressively decreased after the onset
of reps on. Compared with group i , this group showed a
lower left ventricular ejection fraction (36 t 7% vs. 63 t 15%,
p < 0.01) and a larger t llium,1'21)3 'index (1,091
366 U vs . 247 t 261 U, p < 0.01) at follow-up. Although other
patient characteristics were comparable between the two groups,
antecedent
occurredangina in 90% of group B patients in contrast
to only 33% of group A patients.
Conclusions. Salvage of myocardium from infarction by suc-
cessful th bolysis was not observed in the patients demonstrat-
ing progressive decreases in great cardiac vein flow (group A) . In
those patients, inadequate myocardial reperfusion on a microvas-
cular bads might be associated with a much larger myocardial
Infarction . Antecedent angina may protect against a progressive
decrease in coronary How and may have beneficial effects on
infarct size limitation .
(J Am Coll Cardiol 1994;24:370-7)
sis after reperfusion (4), longer intervals between the onset
of infarction and reperfusion (5), an increase in coronary
vascular resistance due to oxygen-derived free radicals (6),
endothelin (7), angiotensin 11 (8), thromboxane A 2 (9) and
leukocyte infiltration (10) . The observation that blood flow
may not be restored in some regions of reperfused infarcts,
described as the "no reflow phenomenon" (11,12), has been
demonstrated both experimentally (13,14) and clinically
(15,16) . An experimental study (13) suggested that leukocyte
accumulation and capillary plugging are related to the "de-
layed no reflow," that is, a delayed progressive reduction in
coronary flow to areas that initially receive adequate reper-
fusion . If these processes also occur in the clinical setting,
timely thrombolysis in acute myocardial infarction may not
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fully perfuse the ischemic myocardium and, hence, may not
recover the processes of cellular injury .
In the present study, we tested the hypothesis that there
is a correlation between indexes of infarct size at follow-up
and progressive decreases in coronary vein flow during tae
early phase of complete reperfusion . To examine this idea,
we serially measured coronary vein flow in patients with
early reperfusion in transmural anterior infarction and as-
sessed infarct size by left ventriculography and thallium-201
scintigraphic study at follow-up .
Methods
Study patients. One hundred seven consecutive patients
with evolving anteroseptal myocardial infarction were en-
rolled into the thrombolysis and rescue coronary angioplasty
protocol of our hospital . All gave written informed consent
for diagnostic and therapeutic catheterization as well as for
participation in this study protocol, which was approved by
the Osaka Police Hospital Ethical Committee . Coronary
recanaUzation was successful in 80 of the 107 patients .
The study group comprised the 19 patients (17 men, 2
women; mean age ± SD 57 ± 12 years) with successful
coronary revascularization who fulfilled the following crite-
ria: 1) no history of previous myocardial infarction ; 2) total
occlusion of the proximal portion of the left anterior de-
scending coronary artery at initial angiography and no
significant ('75% diameter reduction) stenosis in the re-
maining coronary arteries; 3) no opaciflable collateral ves-
sels on initial and follow-up angiography ; 4) performance of
all studies when arterial partial pressure of oxygen (Pao 2) p11
and hemoglobin concentration were normal ; 5) no use of
inotropic agents, beta-adrenergic blocking agents or calcium
channel blockers during the study ; 6) recanalization by :s5 h
of the onset of symptoms with Thrombolysis in Myocardial
Infarction (TIMI) grade 3 flow (17) without high grade
(>90%) residual stenosis ; 7) neither reocclusion nor resten-
osis of the infarct-related vessel on follow-up angiography ;
8) no observed clinical events, such as recurrent ischemic
pain, cardiac arrest, congestive heart failure, reinfarction,
revascularization by bypass surgery or in-hospital death .
The diagnosis of acute myocardial infarction was deter-
mined on the basis of a history of chest pain that lasted
>30 min, was associated with electrocardiographic (ECG)
changes suggestive of acute ischemia in at least two leads
and did not respond to nitroglycerin administration . The
diagnosis was subsequently confirmed by evolutional ECG
changes and elevation of plasma creatine kinase activity .
flactrocardQaphic assessment of risk area. The ST
segment-predicted risk area was determined from the initial
in-hospital ECG recording. The following formula based on
the number of ST segment elevations a0.1 mV (nST) in the
standard 12 leads was used for prediction (18,19)
: ECG risk
area = 3[1 .5(nST) - 0.4] (%) . This formula was validated in
the Second International Study of Infarct Survival (18,20) .
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Catheteriaatinn and Eligible patients un-
derwent cardiac catheterization by the percutaneous femoral
approach and received intravenous heparin, 5,000 U . After
angiographic confirmation of total occlusion of the left
anterior descending coronary artery, intracoronary nitro-
glycerin, 0 .1 mg, was subsequently administered to exclude
vasospasm and intracoronary urokinase, 960,000 U, was
administered during 45 to 60 min; if necessary, rescue
angioplasty was performed . The time of recanalization was
confirmed by angiography every 15 min, and the correspond-
ing perfusion status after recanalization was identified with
the use of an adequate amount of contrast material . Success-
ful recanalization was defined as TIM[ grade 3 perfusion
(17) . Coronary angioplasty was performed when TIM[ per-
fusion grade was <3 or percent residual diameter stenosis
was >90%. Minimal percent diameter stenosis was ex-
pressed using the methods of Ad Hoc Committee of the
American Heart Association (21) .
Measurements of systemic hemodynianle variables and
great cardiac vein flow . The standard hemodynamic mea-
surements, including systemic and pulmonary artery cathe-
terization, were monitored throughout the procedures with
catheters introduced percutaneously by way of the femoral
artery and vein . The hemodynarnic subset of Forrester et al .
(22) at hospital admission was determined . The 7F coronary
vein multithermistor thermodilution catheter (Wilton Web-
ster laboratories) was inserted percutaneously from the left
arm by cutdown of antecubital vein and advanced to the
great cardiac vein. Catheter position was monitored by
injection of a small volume of contrast medium, and the
stable catheter position was frequently confirmed by fluo-
roscopy using a minimal amount of contrast agent during the
whole procedure . Great cardiac vein flow was measured by
continuous thermodilution technique (23,24), infusing 5%
dextrose in water at a rate of 40 mYmin for 30 s with an
angiographicc injector (Medrad Mark IV) . Systemic and
coronary hemodynamic status was determined before
thrombolysis, 60 min after the first angiogram when TIMI
grade 3 flow was obtained, at 6, 12 and 24 h of the onset of
infarction and at follow-up . The time of reperfusion was
within 60 min after the first angiogram . We chose postreper-
fusion flow as baseline flow because 1) confirmation of
reperfusion took X60 min after the first angiogram, when the
peak time of reactive hyperemic flow might be over ; 2) great
cardiac vein flow before reperfusion did not reflect nonoc-
eluded baseline flow but represented coronary vein flow
from nonischemicc areas
Measurements of myocardial oxygen extraction . Oxygen
partial pressure and saturation were determined with a blood
gas analyzer (Corning 2500 CO-oximeter, Corning Medical
and Scientific) . Blood from the aorta and great cardiac vein
were sampled simultaneously before thrombolysis, 60 min
after the first angiogram and at 6, 12 and 24 h after the onset
of symptoms .
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Ventricular performance t follow-up cathete ' lion
.
Follow-up catheterization was performed 46 ± 13 days after
the onset of infarction. Global ejection fraction was calcu-
lated by the standard method of Sandler and Dodge (25) from
traced silhouettes of single-plane left ventriculograms in the
30° right anterior oblique view .
Thalnhram-201 i defect at follow-up. Thallium-201
scintigraphy was performed 38 ± 11 days of the onset of
infarction by a technique previously described (26,27) .
Briefly, 32 projections of thallium-201 single-photon emis-
sion computerized tomography over 180° were obtained 3 h
after intravenous administration of 3 mCi of thallium-201 .
The left ventricle was sliced at equidistant intervals perpen-
'icular to its long axis, and the tomograms were quantified
by maximal couai circumferential profiles at each slice ;
results were compared with normal limit profiles derived
from 60 normal control subjects . Defect areas were defined
as the areas at each slice in which thallium counts decreased
a2 SD below the count distribution in normal control
subjects. Thtave defect areas were weighed for the average
counts in each area, and the sum of these defect areas was
defined as the extent of damaged myocardium in the left
ventricle, that is, "defect severity index ."
Study p . . Systemic hemodynamic and great car-
diac vein flow measurements at baseline and collection of
arterial and great cardiac vein blood samples were made
before thrombolysis . All patients were treated with contin-
uous infusion of nitroglycerin (0 .1 to 0.3 pg/min) for hemo-
dynamic stabilization and with small-dose heparin infusion
(3 to 7 U/min) for prevention of reocclusion during the 1st
24 h after admission. Inotropic agents were not adminis-
tered. In all patients with successful recanalization, systemic
and coronary hemodynamic measurements and blood sam-
pling were repeated 60 min after the first angiogram and at 6,
12 and 24 h of the onset of symptoms . The time of reperfu-
sion when angiography showed TIM[ grade 3 flow was 30 to
60 min after the, first angiogram . All patients underwent
follow-up catheterization 46 ± 13 days after the onset of
infarction. Neither reocclusion nor restenosis of the infarct-
related vessel was proved at follow-up catheterization . Pa-
tients were classified into two groups according to the
pattern of thermodilution measurements of great cardiac
vein flow: group A included 9 patients with a decrease in
great cardiac vein flow >3 of baseline flow during the 1st
24 h of the onset of infarction; Group B included 10 patients
without this observation (Table 1) .
Calculia . Myocardial oxygen extraction (Eo2) was
calculated as Eo2 = C(A - G)o2/CAo2, where C(A - G)o2
and CAo2 represent arterial-great cardiac vein oxygen con-
tent difference and arterial oxygen content, respectively .
Coronary vessel resistance (CVR) was calculated as CVR
(mm
Hg-min/ml) = Mean arterial pressure/Great cardiac
vein flow .
. All data were expressed as mean
value ± SD. An unpaired Student t test was used to compare
values of age, elapsed time, time interval between initial and
Table 1 . Great Cardiac Vein Flow (ml/min) in the 19
Study Patients
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Aft = 60 min after the first angiogram
; Pt = patient ; 6 h . 12 h and 24 h =
6, 12 and 24 h, respectively, after the onset of infarction .
repeat angiography, ECG risk area, systemic hemodynamic
variables and indexes of infarct size between the two groups
of patients. We used regression equations to analyze the
statistical significance of sequential changes in great cardiac
vein flow, oxygen extraction and coronary vessel resistance
over time between the two groups : y = bo + b i t + b2Dt,
where t = time ; D = 0 f group A,1 if group B ; bo = "after"
value; b 1 = slope (over time) for group A ; b2 = change in
slope for group B . If b2 is significant, we can judge that one
of the groups evolves over time differently from the other . A
chi-square analysis with the Yates correction was used to
determine qualitative differences between the two groups
(i.e., gender, hemodynamic subsets of Forrester et al. and
associated rescue angioplasty or antecedent angina) . The
Mann-Whitney U test was used to determine qualitative
differences for residual stenosis in the acute and chronic
phases of infarction. Results were considered significant at
p < 0.05 .
Results
Clinical characteristics of the patients (Table 2) . Age,
gender, hemodynamic subset on admission and time interval
between the initial and repeat angiography were comparable
in the two groups of patients, as were the elapsed time from
the onset of infarction to reperfusion and residual coronary
stenosis after reperfusion and at follow-up . Three of 10
patients in group B and 4 of 9 patients in group A were
treated by rescue coronary angioplasty after thrombolysis
Pt No . Aft 6 h 12 h 24 h
Change
(124 h-Aftl/Aft)
Group A
1 48 45 35 32 -33 .3
2 48 48 43 33 -31 .3
3 71 56 50 38 -46 .5
4 82 70 66 54 -34 .1
5 54 43 26 31 -42 .6
6 72 54 36 30 -58 .3
7 54 47 36 37 -31 .5
8 36 30 24 23 -36 .1
9 59 50 19 11 -81 .4
Group B
1 67 60 52 47 -29.9
2 41 37 43 38 -7.3
3 51 60 54 52 +2.0
4 65 48 49 71 +9,2
5 68 68 65 68 0.0
6 55 65 60 5n -9.1
7 92 86 90 88 -4.3
8 52 50 58 50 -3.8
9 40 41 41 32 -20.0
10 70 70 58 49 -30.0
JACC Vol
. 24, No . 2
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Table 2. Clinical Background of the 19 Study Patients
(p = NS) . In both groups, the thrombi were located at the
proximal segment of the left anterior descending coronary
artery, and there were no opacifiable collateral vessels on
initial or follow-up angiography . The ECG risk area on
admission did not differ between the two groups. Only the
prevalence of antecedent angina, defined as recurrent isch-
emic chest pain beginning >7 days before admission (28),
differed between the two groups (90% in group B patients in
contrast to 33% in group A patients). After reperfusion, no
patient had recurrent infarction or prolonged angina, con-
gestive heart failure or cardiac arrest during the in-hospital
period .
Systemic hemodynamic changes (Table 3). Table 3 sum-
marizes the changes in hemodynamic variables in the two
groups during the study . Heart rate and systolic and mean
arterial blood pressures in both groups were unchanged
throughout the study, and there was no significant difference
between the two groups in each variable at any time point .
Pulmonary capillary wedge pressure decreased significantly
(p < 0.05) after reperfusion in both groups, and thereafter
it was unchanged during the study . There was no difference
in capillary wedge pressure between the two groups
. At
follow-up left ventriculography, systemic hemodynamic
variables were also similar between the two groups .
KOMAMURA ET AL
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Angio Interval = interval between initial and repeat angiography ; ECG risk = electrocardiographic risk area
;
F = female -, F/U = follow-up ; M = male
; Pt = patient ; PTCA = percutaneous transluminal coronary angioplasty ;
Time to Repeif = time from onset of infarction to reperfusion
; - = no ; + = yes .
Changes in great cardiac vein flow (Fig . 1). In group B,
mean great cardiac vein flow did not change during the
study. However by definition, in group A, great cardiac vein
flow gradually decreased by 26 ± 13 mUmin (mean ± SD) or
44 ± 17% from the postreperfusion flow (58 ± 15 mUmin)
during the 1st 24 h of the onset of infarction . Regression
equation for analysis of significance over time between the
two groups was y = 60 .7 - 1.32t + 1 .05Dt, where t = time ;
D = 0 if group A,1 if group B (see Statistical analyses under
Methods). Coefficient of 1 .05Dt was significant (p < 0 .0001),
indicating that great cardiac vein flow evolved over time
differently in group A than in group B .
Regional oxygen extraction (Fig. 2). Figure 2 demon-
strates that mean myocardial oxygen extraction was gradu-
ally decreased in group A by 0.25 ± 0 .13 or 38 ± 15% from
the postreperfusion value of 0.64 ± 0
.11 Regression equa-
tion for analysis of significance over time between the two
groups was y = 0 .622 - 0.0104t + O.W6161)1, where t =
time; D = 0 if group A, I if group B . Coefficient of 0
.00616Dt
was significant (p < 0 .001), indicating that oxygen extraction
in group A evolved over time in a manner different from that
in group B. In group B, oxygen extraction did not change
during the study .
Coronary vessel resistance (Fig. 3)
. After reperfusion in
Pt No .
Age (yr)!
Gender
Forrester
Hemodynamic
Subset
Time to
Reperf
N PT CA
Residua]
Stenosis
Angio
Interval
(days)
ECG Antecedent
Risk 1%)
Angina
-_
Acute
phase VU
Group A
1 J8/m 1 3 .7
90 50 42 12 .3 +
2 65/M 1 2 .4 25 25 58
16 .8
3 ON 1 4 .7 90 90 47 12 .3
4 74/M 1
2 .2
50 0 30 21 .3
5 481M 1 1 .7 50 50 33 25 .8
6
43/M
1
2 .7
90 90 36
12
.3
+
7
641M 1 4 .9
90 90 60 21 .3
8 61(M 2 5 .0 90 90 59 16 .8
9 301M 2 3 .8 90 25 33 16 .8
Mean 54 3 .5 74 57 44 17 .3
SD 14 1 .3 25 35 12 4 .7
Group B
I 54/M 1 2 .1 9d 50 30 12 .3
2 601M 1 2 .0
90 75 54
12 .3
3
70/M 1 2 .5 75 75 73 16.8 +
4
60/F 1 2 .8 0 0 66 21 .3 4
5 56/F 1 2.2 90 90 36 12 .3 +
6 441M 1 4.0 75 75 38 21 .3 +
7 62/M 1 4 .4 90 75 33 12 .3
+
8 66/M 1 4 .5
90 90 39 16.8 +
9 711M 1
4
.0
90 90 70 25 .8 +
10 461M 1 3 .0
90 90 29 16.8
+
Mean 59
3 .2 78 71 47 16.8
SD 9 1 .0 28 28 17 4.7
'p < 0.05 versus before reperfusion . Other abbreviations as in Tables I and 2 .
group B, mean coronary vessel resistance remained un-
changed throughout the study . Group A demonstrated grad-
ual increases in coronary vessel resistance by 1 .60 ± 1 .59
from 1 .52 ± 0 .28 mm Hg-min/ml during the 1st 24 h of the
onset of infarction . Regression equation for analysis of
significance over time between the two groups was y
1 .31 + 0.0774t - 0.0664Dt, where t = time ; D = 0 if group
A, I if group B. Coefficient of -0.0664Dt was significant
(p < 0.0001), indicating that coronary vessel resistance in
group A evolved over time in a manner different from that in
group B .
Veutrlcular wall motion and sclntl phic analyses at
-up (Fig . 4). Group B showed a significantly (p < 0.01)
higher global ejection fraction (63 ± 15%) than that of group
Fkure 1. Serial changes in great cardiac vein flow in groups A and
B. The
	
Rue represents the linear regression for group A, the
du&W In that for group B. The regression equation for aralysis
of significance over time between the two groups was y = 60 .7 --
1 .321 + 1 .051)1, where t = time ; D = 0 if group A, I if group B . The
time course in group A was significantly different from that in group
B (p < 0.1)8!1) . aft = 60 min after the initial angiogram ; 6 h, 12 h and
24 h = 6,12 and 24 h, respectively, after the onset of infarction .
so
ea -
42 -
0
i group A
O group B
(rnean+SD)
Olt 6h 12h
Time
24h
C
07
xx
0
0 .2
0-
a group A
0 group B
(mecn±SD)
aft 6h 128
Time
A (36 ± 7%). Ejection fraction was measured at follow-up
catheterization, when systemic hemodynamic variables
were comparable between the two groups (Table 2) . Group B
had a significantly (p < 0 .01) smaller defect severity index
than that of group A (247 ± 261 U vs . 1,091 ± 366 U, p <
0.01) .
Discussion
The major finding of this study was that limitation of
myocardial infarct size was attenuated in the patients who
demonstrated progressive decreases in great cardiac vein
flow even after successful early recanalization. In the pa-
tients who did not show progressive decreases in great
cardiac vein flow, infarct size was smaller . Except for a
Figure 2. Serial changes in regional oxygen extraction in groups A
and B. The solid line represents the linear regression for group A, the
Nee that for group B . The regression equation for analysis of
significance over time between the two groups was y = 0 .622 -
0.0104t + 0.00616Dt, where t = time ; i) = 0 if group A,1 if group B .
The time course in group A was significantly different from that in
group B (p < 0 .001) . Abbreviations as in Figure 1 .
08 -
C 05
0
V
O
L
X
W 0.4
248
I
Before
Reperfusion 6h 12 h
24 h F/U
Heart rate (beats/min)
Group A 92-3 :t 18 .3 92 .2 ± 17 .0 85 .9 ± 16.1 88.0 ± 14 .0
90.9 ± 12 .9 86.1 ± 12,6
Group B 4±16 .7 79.2±12.1
75 .8 ± 15 .2 82.2 ± 13 .8 84.1±10.4 82 .1 ± 11 .6
Pressures (min Hg)
Systolic aortic
Group A 119.7 ± 18 .9 119.0*10.0 117 .0 ± 13 .8 112.1 ± 18 .5
111.1*15.6 123.0±18.7
Group B 127.0±21.0 126 .0 ± 14.7 120.0 ± 17 .0 114.6 ± 15,8
111.0±7.0 118 .2 ± 9 .7
mean amic
Group A 95.1 ± 17 .8 85 .0 ± 11 .0
83.4±8.5 79.4±° 10 .7 84.3 ± 10 .5 91.9± 12 .8
Group 6 91 .9 ± 10 .6 89.2±8.0
85 .1 ± 11 .9 78.1 ± 11 .4 79.1 ± 8 .4 82 .8 ± 5 .8
Pulmonary capillary
Group A 14.426.0 12 .1 ± 4 .2 4 10 .4 ± 3 .8* 9.4 ± 3 .7°' 9.8 ± 2 .9* 7 .9 t 2.1'"
Group B 14.4 ± 8.3 10 .7 ± 4 .8° 9 .0 ± 2 .34 8.3±22* 8.6 ± 3 .1* 7 .6 ± 4.5*
374
XOMAIMURA ET AL.
JACC Vol . 24, No. 2
T
PROGRESSIVE DECREASES IN CORONARY VEIN FLOW
3. Systemic Hemodynamic Changes in Groups A and B
August 19+4 :370 7
JACC Vol . 24, No . 2
August 1994
.370-7
croup A
group
°
	
SL
3
0
(it" 611 12h 24h
Time
Figure 3 . Serial changes in coronary artery resistance in groups A
and B . The solid line represents the linear regression forgroup A, the
dashed One that for group B . The regression equation for analysis of
significance over time between the two groups was y ~ 1 .31 +
0.0774t - 0.%UDt, where t = time ; B = 0 if group A, I if group B .
The time course in group A *as significantly different from that In
group B (p < 0.0001) . Abbreviations as in Figure I .
much greater frequency of antecedent angina in group B, the
two groups of patients had apparently homogeneous clinical
characteristics (i .e ., left anterior descending coronary artery
occlusion with no collateral flow, moderate size of ECG risk
area and complete reperfusion within 5 h of the onset of
infarction) .
Possible mechanisms of reduction in great cardiac vein flow
and failure of infarct size limitation despite early successful
recanalization . There are several possible mechanisms of
decreased great cardiac vein flow after reperfusion. 1) Met-
abolic demand of reperfused myocardium might decrease
because disappearance of ischemia may attenuate sympa-
thetic nerve stimulation . However,
heArt rate and aortic
Figure 4 . Differences in left ventricular
ejection fraction (left panel) and thallium-
201 defect severity index (right panel) be-
tween groups A and B. Group A had a
40
significantly (**) lower (p < 0.01) ejection
fraction and a larger (p < 0.01) defect size
compared with group B .
Group A
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pressure did not change in either patient group throughout
the study. 2) Epicardial coronary spasm after recanalization
may decrease coronary blood flow . In this case, oxygen
extraction might have increased (29) . However, oxygen
extraction after recanalization was decreased in our patients,
and there was no evidence of recurrent ischernia during the
study. 3) Coronary microvascular injury in reperfused myo-
cardium may decrease great cardiac vein flow . In pathologic
studies of myocardial infarction, leukocyte plugging (30) and
platelet aggregation (31) are often observed during reperfu-
sion and are suggested to cause the disturbances of micro-
circulation . In experimental obstruction of coronary micro-
circulation (32), microvascular embolization decreased
oxygen extraction with massive releases of lactate and
decreased coronary blood flow. These situations correspond
well with our observations . Functional microvascular distur-
bances, such as capillary compression by myocardial tissue
edema (33), myocardial ischemic contracture (34), endothe-
lial cell swelling (35) and increases in vasomotor tone (36),
are also possible causes of microvascular injury after reper-
fusion .
In previous clinical studies (15,16), myocardial imaging
by contrast echocardiography or thallium-201 scintigraphy
was used to prove the presence of a no reflow zone . In the
present study, we used no index of myocardial perfusion in
the acute phase of infarction and measured only coronary
venous flow and coronary vessel resistance . Ambrosio et al .
(13) have shown that no reflow zones are characterized by
abrupt vascular occlusion at both small arteriolar and venu-
lar levels and absence of capillary filling. Kloner and col-
leagues (37) revealed progressive microvascular damage
after reperfusion characterized by neutrophil migration into
the vessel wall and erythrocyte stasis. Furthermore, these
abnormalities were associated with reduced vasodilator re-
serve. Another pathologic study (38) demonstrated progres-
sive infarct extension during reperfusion . Experimental
(unit)
2000
Group B
1500
1000
500
0
Group A Group B
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studies (14,32) of no reflow demonstrated a progressive
decrease in myocardial perfusion . Our results are consistent
with those findings . The progressive reduction in great
cardiac vein flow strongly suggests progressive impairment
of anterograde flow . Because we did not measure white
blood cell count in the coronary venous blood, we could not
confirm that there was leukocyte plugging in the ischemic
myocardium. However, white blood cell count in the periph-
eral blood was higher in group A than in group B (15,667 ±
2,872 vs. 11,300 ± 2,177lµ1, p < 0 .05), raising the possibility
that the inflammatory response to ischemia might be one
difference between the two groups .
Study limitations . Although thermodilution measure-
ments of great cardiac vein flow have been previously
validated in humans and widely used in clinical studies
(23,39), this procedure has some technical limitations
(40,41) . However, changes >30% in great cardiac vein flow
can be considered significant (24,42,43) . In the present
study, extreme care was taken to stabilize and document the
catheter position when great cardiac vein flow was measured
repeatedly . We found that patients in group A showed
decreases in great cardiac vein flow of 44% or 26 ml/min,
indicating that in a particular subset of patients, great cardiac
vein flow substantially decreases during the acute phase of
infarction . It is possible that decreases in myocardial perfu-
sion are attributable to decreases in collateral flow from
nonischemic regions (44) . However, this possibility does not
seem likely, because no opacifiable collateral vessels were
observed during coronary angiography .
Nicklas et al . (45) showed a mean increase of 12 .9% in
great cardiac vein flow after recanalization in myocardial
infarction in humans . Our patients had a mean hyperemic
increase in great cardiac vein flow of 7.2%. Possible causes
for the decreased hyperemia are 1) we measured the post-
reperfusion flow after confirmation of 1IMI grade 3 flow,
which took :560 min after the first angio , indicating that
the peak time of reactive hyperemia might be over; 2) the
great cardiac vein flow measurement before reperfusion
should have reflected coronary vein flow from nonischemic
areas; hence, reactive hyperemia in the present study might
not be similar to that in the experimental studies .
It is difficult to estimate infarct size by means of wall
motion abnormality in the follow-up period, because stunned
myocardium (46) may be assessed as infarct area even
though impaired contractile dysfunction in stunned myocar-
dium is reversible. Because myocardial stunning is reported
to restore its basic contractile function 10 to 16 days after
reperfusion (47,48) and we estimated ventricular wall motion
46 ± 13 days after recanalization, our estimation of infarct
size may not include reversibly injured myocardium . In
addition, differences in loading conditions in the acute and
chronic phases of infarction may cause erroneous estimates
of ventricular wall motion
. However, the assessment of
infarct size by ventricular wall motion in the two comparable
loading conditions is reported to cause minimal errors (49).
Furthermore, we assessed infarct size with thallium-201
defect severity, which is not affected by abnormal wall
motion of salvaged myocardium . Taken together, the esti-
mation techniques of infarct size in the present study seem to
provide a precise extent of necrotic area.
Ischemic preconditioning is believed to limit infarct size
in reperfused myocardium experimentally (50) and also
clinically (51) . Various plausible mechanisms of this phe-
nomenon such as free radical generation and scavenging (52)
or endogenous adenosine (53) are proposed. Our definition
of antecedent angina is different from that of experimental
ischemic preconditioning . However, most of our study pa-
tients without clinical demonstration of the no reflow phe-
nomenon had antecedent angina . Because no established
data have linked preconditioning to the no reflow phenome-
non, we need to further investigate the general aspect of
microvascular disturbances in acute myocardial infarction .
Conclusions . Salvage of myocardial infarction by early
successful thrombolysis could not be observed in the pa-
tients demonstrating progressive decreases in great cardiac
vein flow . Those patients appeared to have inadequate
myocardial reperfusion on a microvascular basis, which is
associated with a much larger infarction. Antecedent angina
may have beneficial effects on the no reflow phenomenon or
infarct size limitation, or both .
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